Infliximab in the management of severe and refractory psoriasis
Laura Mahiques-Santos(Hospital General Universitario De Valencia), V. Oliver‐Martínez(Hospital General Universitario De Valencia), Teresa Martínez‐Menchón(Instituto de Salud Carlos III), José Luis Sánchez‐Carazo
Cited by 0
Related Papers
NAMPT-derived NAD+ fuels PARP1 to promote skin inflammation through parthanatos cell death
|PLoS Biology|2021|59
Squamous cell carcinoma over tattoos
|Journal of the American Academy of Dermatology|2007|39
Phacomatosis Pigmentokeratotica: A 20‐Year Follow‐up with Malignant Degeneration of Both Nevus Components
|Pediatric Dermatology|2005|38
Models of human psoriasis: Zebrafish the newly appointed player
|Developmental & Comparative Immunology|2019|38
Hydrogen peroxide in neutrophil inflammation: Lesson from the zebrafish
|Developmental & Comparative Immunology|2019|33